KDM3A and neoplasm: Remarkably, KDM3A knockdown not only significantly inhibited tumor growth of MDA-MB-231 cells in vivo but also suppressed metastasis in nude mice, providing further support for the potential therapeutic targeting of KDM3A in TNBC.